Mar 14 2013
The Heart.org posted a small but powerful study today illustrating that dabigatran (Pradaxa) may shorten the inpatient stay because it eliminates the need for coverage by heparin or fondaparinux and eliminates the need to tinker with dosage to hit the target international normalized ratio (INR). Yet more good new for dabigatran. Geo.
Comments (0)Anticoagulant Therapy
No comments here.